During an atrial fibrillation ablation procedure, a pericardial effusion occurred.Transseptal puncture was performed and the tacticath quartz ablation catheter was advanced into the left atrium and ablation was initiated.After approximately one hour, the patient became hypotensive and an echocardiogram revealed a pericardial effusion, for which a pericardiocentesis was performed to stabilize the patient and the procedure was stopped.There were no alleged performance issues with any sjm devices.
|
(b)(4).The results of the investigation are inconclusive since the device was not returned for analysis; however, the log files from the tactics quartz system were returned.Review of the log files revealed the device functioned as intended and there were no contributing anomalies.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.The review determined the process was performed and completed in accordance with sjm specifications and procedures.The cause of the reported pericardial effusion may have been procedure related.Per the ifu, cardiac perforation is a known risk during the use of this device.
|